• Tchaikapharma obtained a new marketing authorisation for the anti-infective solution Levor

    January 22, 2016

    Levor 5 mg/ml infusion solution is a medicinal product of Tchaikapharma High Quality Medicines Inc., for which the Bulgarian Drug Agency issued a marketing authorisation in January 2016. The active substance is levofloxacin as levofloxacin hemihydrate.

    Levor should be used in adults for treatment of the following infections:

    • Community acquired pneumonia;
    • Complicated skin and soft-tissue infections.

    ATC code: J01MA12